Low-Dose Calcium Noninferior for Reducing Risk of Preeclampsia

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Jan. 11, 2024 -- Low-dose calcium supplementation is noninferior to high-dose supplementation for reducing the risk of preeclampsia, according to a study published in the Jan. 11 issue of the New England Journal of Medicine.

Pratibha Dwarkanath, Ph.D., from St. John's Research Institute in Bangalore, India, and colleagues conducted two independent randomized trials of calcium supplementation in pregnancy in India and Tanzania to assess the noninferiority of a 500-mg daily dose to a 1,500-mg daily dose. The two primary outcomes in each trial were preeclampsia and preterm birth; the noninferiority margins for the relative risks were 1.54 and 1.16, respectively.

Each trial included 11,000 nulliparous pregnant women. The researchers found that the cumulative incidence of preeclampsia was 3.0 and 3.6 percent, respectively, in the 500- and 1,500-mg groups in the India trial (relative risk, 0.84; 95 percent confidence interval, 0.68 to 1.03), and 3.0 and 2.7 percent, respectively, in the Tanzania trial (relative risk, 1.10; 95 percent confidence interval, 0.88 to 1.36); these values were consistent with the noninferiority of the lower dose in both trials. The percentage of preterm births was 11.4 and 12.8 percent in the 500- and 1,500-mg groups, respectively, in India (relative risk, 0.89; 95 percent confidence interval, 0.80 to 0.98), which was within the noninferiority margin; the corresponding percentages were 10.4 and 9.7 percent in the Tanzania trial (relative risk, 1.07; 95 percent confidence interval, 0.95 to 1.21), which exceeded the noninferiority margin.

"The 500-mg dose that we studied as a comparator reduces the pill burden and would be expected to reduce program costs," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-12 04:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords